Jo Fuller, 51, is spending thousands on experimental treatments for glioblastoma that she hopes will extend her life
Eleanor Hayward is a Health Editor at The Times. She reports from medical conferences around the world and covers all aspects of the NHS, focusing on key issues affecting patients, including public health, oncology, and mental health care. Eleanor's work has been featured in The Australian, Cairns Post, The Post, World Wealth Journal, Waikato Times, and The Press.














